Sign in

CIK 0001799191

  • Accelerated filer
  • Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN STLNW DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843562323
Phone
+1 562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Common stock Nasdaq
  • DFPH Common stock OTC
  1. 4/A Open-market buy Director bought 45,280 shares at $1.04 ($47,168)
  2. 4 Grant or award Chief Medical Officer acquired 157,088 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 197,368 shares (grant or award)
  4. 4 Grant or award Chief Operating Officer acquired 162,281 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 1,083,334 shares (grant or award)
  6. 4 Grant or award Director acquired 2,716,898 shares (grant or award)
  7. 4 Open-market buy Chief Executive Officer bought 22,640 shares at $1.04 ($23,584)
  8. 4 Open-market buy Chief Medical Officer bought 9,056 shares at $1.04 ($9,434)
  9. 4 Open-market buy Director bought 90,562 shares at $1.04 ($94,338)
  10. 4 Open-market buy Director bought 36,224 shares at $1.04 ($37,735)
  11. 4 Open-market buy Director bought 9,056 shares at $1.04 ($9,434)
  12. 4 Open-market buy Chief Operating Officer bought 9,056 shares at $1.04 ($9,434)
  13. 4 Open-market buy Chief Financial Officer bought 9,056 shares at $1.04 ($9,434)
  14. 4 Open-market buy Director bought 1,358,448 shares at $1.04 ($1,415,095)
  15. 4 Returned to the company Chief Executive Officer returned 10,261 shares (to the company)
  16. 4 Returned to the company Chief Medical Officer returned 2,975 shares (to the company)
  17. 4 Returned to the company Chief Financial Officer returned 1,150 shares (to the company)
  18. 4 Returned to the company Chief Financial Officer returned 258 shares (to the company)
  19. 4 Returned to the company Chief Operating Officer returned 1,130 shares (to the company)
  20. 4 Open-market buy Director bought 300,000 shares at an average $0.17 ($50,000)

Page 5 of 14 · 269 filings